[Vaccine against human papillomavirus : PATRICIA Study (PApilloma TRIal against Cancer In young Adults)].
Kaufmann
A M
AM
Gynäkologische Tumorimmunologie, Gynäkologie, Campus Mitte und Benjamin Franklin, Charité Universitätsmedizin Berlin, Berlin, Deutschland. andreas.kaufmann@charite.de
Nitschmann
S
S
D000293:Adolescent; D000328:Adult; D004311:Double-Blind Method; D005260:Female; D052162:Human papillomavirus 16; D052161:Human papillomavirus 18; D006801:Humans; D032541:Mass Vaccination; D009367:Neoplasm Staging; D030361:Papillomavirus Infections / Q000150:complications / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D053918:Papillomavirus Vaccines / Q000276:immunology*; D011230:Precancerous Conditions / Q000517:prevention & control / Q000821:virology; D012449:Safety; D012725:Sexual Behavior; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D014626:Vaginal Smears; D055815:Young Adult; D002578:Uterine Cervical Dysplasia / Q000276:immunology / Q000517:prevention & control* / Q000821:virology
D053918:Papillomavirus Vaccines; C510352:human papillomavirus vaccine, L1 type 16, 18